Item 7.01 Regulation FD Disclosure
On
A copy of the Investor Presentations are attached as Exhibit 99.1 and Exhibit 99.2 to this Current Report on Form 8-K. The Company expects to use the Investor Presentations, in whole or in part, and possibly with modifications, in connection with presentations to investors, brokers, analysts, and others.
The Investor Presentations include financial information not prepared in accordance with generally accepted accounting principles ("Non-GAAP Financial Measures"). A reconciliation of the Non-GAAP Financial Measures to financial information prepared in accordance with generally accepted accounting principles ("GAAP"), as required by Regulation G, appears at the end of the presentations. The Company is providing disclosure of the reconciliation of reported Non-GAAP Financial Measures used in the Investor Presentations, among other places, to its comparable financial measures on a GAAP basis. The Company believes that the Non-GAAP Financial Measures provide investors additional ways to view the Company's operations, when considered with both the GAAP results and the reconciliation to non-GAAP financial information, which the Company believes provide a more complete understanding of the business than could be obtained absent this disclosure.
The information in this Item 7.01 and in Exhibit 99.1 and Exhibit 99.2 is
summary information that is intended to be understood in the context of the
Company's
The information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed subject to the requirements of amended Item 10 of Regulation S-K, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The furnishing of this information hereby shall not be deemed an admission as to the materiality of such information.
The information in this report and in Exhibit 99.1 and Exhibit 99.2 hereto may
contain "forward-looking statements" within the meaning of Section 27A of the
Securities Act and Section 21E of the Exchange Act. All statements, other than
statements of historical or current fact, are statements that could be deemed
forward-looking statements, including, without limitation, statements relating
to the integration of MRI assets, the impact on long-term adjusted EBITDA
margins for the MRI division, expected cost-cuts, the impact of lost franchisees
on the system, pro forma financial information, system sales, revenue, expenses,
or income at the corporate or franchise level, capital outlays, consequences,
and all other statements that are not purely historical in nature.
Forward-looking statements are based on the current beliefs, assumptions, and
expectations of management and current market conditions. There can be no
assurance that such expectations will be met. The Company's actual results may
be significantly different. You should not place undue reliance on
forward-looking statements. Factors that may cause actual results to differ
materially from those contemplated in any forward-looking statements made by us
are sometimes presented within the forward-looking statements themselves or are
otherwise discussed in filings we make with the
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 First Investor Presentation (furnished only) 99.2 Second Investor Presentation (furnished only) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source